150 related articles for article (PubMed ID: 25158160)
1. Endothelial progenitor cells in clinical settings.
Sanada S; Taniyama Y; Azuma J; Yuka II; Iwabayashi M; Rakugi H; Morishita R
J Stem Cells; 2014; 9(2):117-25. PubMed ID: 25158160
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
Kaga T; Kawano H; Sakaguchi M; Nakazawa T; Taniyama Y; Morishita R
Vascul Pharmacol; 2012 Aug; 57(1):3-9. PubMed ID: 22361334
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence.
Sanada F; Taniyama Y; Azuma J; Iekushi K; Dosaka N; Yokoi T; Koibuchi N; Kusunoki H; Aizawa Y; Morishita R
Hypertension; 2009 Jan; 53(1):77-82. PubMed ID: 19047582
[TBL] [Abstract][Full Text] [Related]
4. The role of FGF2 in migration and tubulogenesis of endothelial progenitor cells in relation to pro-angiogenic growth factor production.
Litwin M; Radwańska A; Paprocka M; Kieda C; Dobosz T; Witkiewicz W; Baczyńska D
Mol Cell Biochem; 2015 Dec; 410(1-2):131-42. PubMed ID: 26314253
[TBL] [Abstract][Full Text] [Related]
5. Cellular senescence, cardiovascular risk, and CKD: a review of established and hypothetical interconnections.
Tsirpanlis G
Am J Kidney Dis; 2008 Jan; 51(1):131-44. PubMed ID: 18155543
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic angiogenesis for diabetes mellitus related ischemic disease].
Taniyama Y; Sanada F; Morishita R
Nihon Rinsho; 2010 May; 68(5):949-52. PubMed ID: 20446597
[TBL] [Abstract][Full Text] [Related]
7. Priming Dental Pulp Stem Cells With Fibroblast Growth Factor-2 Increases Angiogenesis of Implanted Tissue-Engineered Constructs Through Hepatocyte Growth Factor and Vascular Endothelial Growth Factor Secretion.
Gorin C; Rochefort GY; Bascetin R; Ying H; Lesieur J; Sadoine J; Beckouche N; Berndt S; Novais A; Lesage M; Hosten B; Vercellino L; Merlet P; Le-Denmat D; Marchiol C; Letourneur D; Nicoletti A; Vital SO; Poliard A; Salmon B; Muller L; Chaussain C; Germain S
Stem Cells Transl Med; 2016 Mar; 5(3):392-404. PubMed ID: 26798059
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Lp(a)-induced functional impairment of endothelial cells and endothelial progenitor cells by hepatocyte growth factor.
Iwabayashi M; Taniyama Y; Sanada F; Azuma J; Iekushi K; Okayama K; Chatterjee A; Rakugi H; Morishita R
Biochem Biophys Res Commun; 2012 Jun; 423(1):79-84. PubMed ID: 22634007
[TBL] [Abstract][Full Text] [Related]
9. Cellular senescence in cardiovascular diseases: potential age-related mechanisms and implications for treatment.
Olivieri F; Recchioni R; Marcheselli F; Abbatecola AM; Santini G; Borghetti G; Antonicelli R; Procopio AD
Curr Pharm Des; 2013; 19(9):1710-9. PubMed ID: 23061728
[TBL] [Abstract][Full Text] [Related]
10. Using gene expression profiling to identify the molecular basis of the synergistic actions of hepatocyte growth factor and vascular endothelial growth factor in human endothelial cells.
Gerritsen ME; Tomlinson JE; Zlot C; Ziman M; Hwang S
Br J Pharmacol; 2003 Oct; 140(4):595-610. PubMed ID: 14504135
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of hepatocyte growth factor in smooth muscle cells regulates endothelial progenitor cells differentiation, migration and proliferation.
Zhu G; Huang L; Song M; Yu Z; Wu X; Zhao X; Jin J; Zhao G; Chen J; Yu S
Int J Cardiol; 2010 Jan; 138(1):70-80. PubMed ID: 19095317
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial cell growth factor and fibroblast growth factor 2 expression in patients with critical limb ischemia.
Palmer-Kazen U; Wariaro D; Luo F; Wahlberg E
J Vasc Surg; 2004 Mar; 39(3):621-8. PubMed ID: 14981457
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-17 enhances bFGF-, HGF- and VEGF-induced growth of vascular endothelial cells.
Takahashi H; Numasaki M; Lotze MT; Sasaki H
Immunol Lett; 2005 May; 98(2):189-93. PubMed ID: 15860217
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Angiogenesis by Gene Therapy for Critical Limb Ischemia: Choice of Biological Agent.
Sanada F; Taniyama Y; Azuma J; Yuka II; Kanbara Y; Iwabayashi M; Rakugi H; Morishita R
Immunol Endocr Metab Agents Med Chem; 2014 Apr; 14(1):32-39. PubMed ID: 26005508
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease.
Vaughan EE; Liew A; Mashayekhi K; Dockery P; McDermott J; Kealy B; Flynn A; Duffy A; Coleman C; O'Regan A; Barry FP; O'Brien T
Cell Transplant; 2012; 21(6):1095-107. PubMed ID: 22304991
[TBL] [Abstract][Full Text] [Related]
16. Gene therapy in peripheral artery disease.
Sanada F; Taniyama Y; Kanbara Y; Otsu R; Ikeda-Iwabu Y; Carracedo M; Rakugi H; Morishita R
Expert Opin Biol Ther; 2015 Mar; 15(3):381-90. PubMed ID: 25633211
[TBL] [Abstract][Full Text] [Related]
17. Biological properties of human skeletal myoblasts genetically modified to simultaneously overexpress the pro-angiogenic factors vascular endothelial growth factor-A and fibroblast growth factor-4.
Zimna A; Janeczek A; Rozwadowska N; Fraczek M; Kucharzewska P; Rucinski M; Mietkiewski T; Kurpisz M
J Physiol Pharmacol; 2014 Apr; 65(2):193-207. PubMed ID: 24781729
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy for peripheral arterial disease.
Shimamura M; Nakagami H; Taniyama Y; Morishita R
Expert Opin Biol Ther; 2014 Aug; 14(8):1175-84. PubMed ID: 24766232
[TBL] [Abstract][Full Text] [Related]
19. Expression pattern of fibroblast growth factor (FGF) and vascular endothelial growth factor (VEGF) system members in bovine corpus luteum endothelial cells during treatment with FGF-2, VEGF or oestradiol.
Gabler C; Plath-Gabler A; Killian GJ; Berisha B; Schams D
Reprod Domest Anim; 2004 Oct; 39(5):321-7. PubMed ID: 15367264
[TBL] [Abstract][Full Text] [Related]
20. Aging impairs the angiogenic response to ischemic injury and the activity of implanted cells: combined consequences for cell therapy in older recipients.
Zhuo Y; Li SH; Chen MS; Wu J; Kinkaid HY; Fazel S; Weisel RD; Li RK
J Thorac Cardiovasc Surg; 2010 May; 139(5):1286-94, 1294.e1-2. PubMed ID: 19931095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
